A detailed history of Pfw Advisors LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Pfw Advisors LLC holds 923 shares of VRTX stock, worth $438,028. This represents 0.12% of its overall portfolio holdings.

Number of Shares
923
Previous 922 0.11%
Holding current value
$438,028
Previous $375 Million 2.84%
% of portfolio
0.12%
Previous 0.12%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 11, 2024

BUY
$407.69 - $446.08 $407 - $446
1 Added 0.11%
923 $386 Million
Q4 2023

Jan 22, 2024

SELL
$343.0 - $410.68 $19,894 - $23,819
-58 Reduced 5.92%
922 $375 Million
Q2 2023

Aug 14, 2023

BUY
$314.42 - $351.91 $308,131 - $344,871
980 New
980 $343 Million

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $122B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Pfw Advisors LLC Portfolio

Follow Pfw Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pfw Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pfw Advisors LLC with notifications on news.